Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2000 Feb 19;320(7233):511-2.

Effectiveness of rivastigmine in Alzheimer's disease. Participation in trials should be based on clinical uncertainty, not enforcement

R Bullock, P Passmore, D Wilkinson, R Howard, R Jones
Comment

Effectiveness of rivastigmine in Alzheimer's disease. Participation in trials should be based on clinical uncertainty, not enforcement

R Bullock et al. BMJ. .
No abstract available

PubMed Disclaimer

Comment on

References

    1. Melzer D. New drug treatment for Alzheimer's disease: lessons for healthcare policy. BMJ. 1998;316:762–764. - PMC - PubMed
    1. Collins R, Doll R, Peto R. Ethics of clinical trials. In: Williams CJ, editor. Introducing new treatments for cancer: practical, ethical and legal problems. New York: John Wiley; 1992. pp. 49–65.
    1. Bentham P, Gray R, Sellwood E, Raftery J. Effectiveness of rivastigmine in Alzheimer's disease. BMJ. 1999;319:640–641. . (4 September.) - PMC - PubMed
    1. Bucks RS, Ashworth DL, Wilcock GK, Siegfried K. Assessment of activities of daily living in dementia: development of the Bristol activities of daily living scale. Age Ageing. 1996;25:113–120. - PubMed
    1. Stern Y, Albert A, Sano M. Assessing patient dependence in Alzheimer's disease. J Gerontol. 1994;49:M216–M222. - PubMed